US 12023355
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof
granted A61KA61K35/17A61P
Quick answer
US patent 12023355 (Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof) held by Iovance Biotherapeutics, Inc. expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Iovance Biotherapeutics, Inc.
- Grant date
- Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K35/17, A61P, A61P35/00, A61P35/02